Department of Fish and Wildlife Sciences, College of Natural Resources, University of Idaho, Moscow, ID, USA.
Department of Fisheries and Wildlife Sciences, College of Agriculture and Natural Resources, Michigan State University, East Lansing, MI, USA.
J Fish Dis. 2021 May;44(5):645-653. doi: 10.1111/jfd.13349. Epub 2021 Feb 9.
Salmonid diseases caused by infections of Flavobacterium psychrophilum, the causative agent of bacterial coldwater disease, remain difficult to manage as novel, pathogenic strains continue to emerge in aquaculture settings globally. To date, much of the research regarding treatment options and vaccine development has focused on rainbow trout (Oncorhynchus mykiss), but other inland-reared salmonids are also impacted by this Gram-negative bacterium. As such, Atlantic salmon (Salmo salar) and brook trout (Salvelinus fontinalis) were injection-challenged with a variety of previously reported F. psychrophilum strains isolated from disease diagnostic cases in salmonids, as well as a standard and well-studied F. psychrophilum strain (CSF 259-93) known to be virulent in rainbow trout. In three separate virulence assessments (Trials A, B and C), strains US063 (isolated from lake trout; Salvelinus namaycush) and US149 (isolated from Atlantic salmon) caused a significantly higher cumulative per cent mortality (CPM) relative to other strains in Atlantic salmon (p <.001 for all trials), with US149 causing significantly greater mortality than US063 in Trials A (CPM 97% vs. 65%, p =.008) and B (CPM 96% ± 2.3% vs. 81.33% ± 4.8%, p =.014). Trial C used a lower dose (1.86 × 10 CFU/mL) for US149, resulting in a lower mortality (78.67% ± 9.33%) relative to Trials A and B. CSF259-93 did not cause significant mortality in any trials. In brook trout, the strain 03-179 (originally isolated from steelhead trout; Oncorhynchus mykiss) was significantly more virulent than any other (CPM 100% ± 0%, p <.001), followed by US063 (73% ± 3.8%) and US149 (40% ± 6.1%,) respectively. Again, CSF259-93 did not cause significant mortality relative to a mock challenge treatment. Results provide information about the applicability of strain selection in F. psychrophilum virulence testing in Atlantic salmon and brook trout, demonstrating the high virulence of US063 and US149 for these salmonid species. This information is applicable for the development of therapeutics and vaccines against F. psychrophilum infections and demonstrates the reproducibility of the experimental challenge model.
由嗜冷杆菌引起的鲑鱼病,这种细菌是冷水病的病原体,在全球水产养殖环境中,新的致病性菌株不断出现,因此仍然难以控制。迄今为止,关于治疗选择和疫苗开发的大部分研究都集中在虹鳟鱼(Oncorhynchus mykiss)上,但其他内陆养殖的鲑鱼也受到这种革兰氏阴性菌的影响。因此,大西洋鲑(Salmo salar)和溪红点鲑(Salvelinus fontinalis)被注射了各种以前报道的从鲑鱼疾病诊断病例中分离出来的嗜冷杆菌菌株,以及一种标准的、研究充分的嗜冷杆菌菌株(CSF 259-93),这种菌株已知在虹鳟鱼中具有毒力。在三次独立的毒力评估(试验 A、B 和 C)中,菌株 US063(从湖鳟鱼中分离)和 US149(从大西洋鲑鱼中分离)导致大西洋鲑鱼的累积死亡率(CPM)显著高于其他菌株(所有试验均为 p<.001),US149 在试验 A(CPM 97%比 65%,p=.008)和 B(CPM 96%±2.3%比 81.33%±4.8%,p=.014)中引起的死亡率显著更高。试验 C 对 US149 使用了较低的剂量(1.86×10 个 CFU/mL),导致死亡率相对试验 A 和 B 降低(78.67%±9.33%)。CSF259-93 在任何试验中均未引起显著的死亡率。在溪红点鲑中,03-179 株(最初从虹鳟鱼中分离)比其他任何菌株的毒力都显著更高(CPM 100%±0%,p<.001),其次是 US063(73%±3.8%)和 US149(40%±6.1%)。同样,CSF259-93 与模拟挑战处理相比,未引起显著的死亡率。结果提供了有关在大西洋鲑鱼和溪红点鲑鱼中嗜冷杆菌毒力试验中菌株选择适用性的信息,表明 US063 和 US149 对这些鲑鱼物种具有高度的毒力。这些信息适用于开发针对嗜冷杆菌感染的治疗方法和疫苗,并证明了实验性挑战模型的可重复性。